Malcolm Gefter is listed as a director on 3 SEC Form D filings by 2 issuers between Nov 2010 and Oct 2012: Edesa Biotech, Inc. (Markham, Ontario, Canada (as filed: A6) — biotechnology — 2012; $15M reported sold to 50 investors) and STELLAR BIOTECHNOLOGIES INC. (Port Hueneme, CA — biotechnology — 2010–2011; $2.78M reported sold to 20 investors).
What this means 2 separate companies raised money with this person listed as director, over about 2 years. Across those companies the filings report $17.8M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Malcolm Gefter and found 6 differences: Malcolm Gefter appears on 1 deal that stopped filing before reaching its target; Form D filed 21 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.